Market closed
Simulations Plus/$SLP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Simulations Plus
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Ticker
$SLP
Sector
Trading on
Industry
Health Care Technology
Headquarters
Employees
245
Website
Simulations Plus Metrics
BasicAdvanced
$534M
66.40
$0.40
0.79
$0.12
0.90%
Price and volume
Market cap
$534M
Beta
0.79
52-week high
$50.98
52-week low
$24.00
Average daily volume
164K
Dividend rate
$0.12
Financial strength
Current ratio
4.149
Quick ratio
3.181
Long term debt to equity
0.452
Total debt to equity
0.715
Dividend payout ratio (TTM)
43.82%
Management effectiveness
Return on assets (TTM)
2.58%
Return on equity (TTM)
4.60%
Valuation
Price to earnings (TTM)
66.399
Price to revenue (TTM)
7.145
Price to book
2.89
Price to tangible book (TTM)
17.31
Price to free cash flow (TTM)
68.45
Dividend yield (TTM)
0.45%
Forward dividend yield
0.90%
Growth
Revenue change (TTM)
19.84%
Earnings per share change (TTM)
-24.72%
3-year revenue growth (CAGR)
15.60%
3-year earnings per share growth (CAGR)
-7.16%
3-year dividend per share growth (CAGR)
-9.14%
What the Analysts think about Simulations Plus
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Simulations Plus stock.
Simulations Plus Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Simulations Plus Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Simulations Plus News
AllArticlesVideos
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences
Business Wire·1 month ago
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements
Business Wire·2 months ago
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Simulations Plus stock?
Simulations Plus (SLP) has a market cap of $534M as of March 13, 2025.
What is the P/E ratio for Simulations Plus stock?
The price to earnings (P/E) ratio for Simulations Plus (SLP) stock is 66.4 as of March 13, 2025.
Does Simulations Plus stock pay dividends?
Yes, the Simulations Plus (SLP) stock pays dividends to shareholders. As of March 13, 2025, the dividend rate is $0.12 and the yield is 0.9%. Simulations Plus has a payout ratio of 43.82% on a trailing twelve-month basis.
When is the next Simulations Plus dividend payment date?
The next Simulations Plus (SLP) dividend payment date is unconfirmed.
What is the beta indicator for Simulations Plus?
Simulations Plus (SLP) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.